Literature DB >> 26588992

Curative therapies for hepatocellular carcinoma: an update and perspectives.

Rodolfo Sacco1, Michela Antonucci2, Giampaolo Bresci1, Ambra Corti3, Luca Giacomelli4, Valeria Mismas1, Maurizio Rainieri5, Antonio Romano1, Roberto Eggenhoffner4, Emanuele Tumino1, Giuseppe Cabibbo5.   

Abstract

Curative treatments, including liver transplantation, surgical resection and percutaneous treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or BCLC-A hepatocellular carcinoma (HCC). This review provides an overview of some issues of clinical importance concerning curative treatments in HCC.

Entities:  

Keywords:  Ablative therapy; HCC; PEI; RFA; early stage; liver transplant; resection

Mesh：

Year:  2015        PMID： 26588992     DOI： 10.1586/14737140.2016.1123625

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  4 in total

1.  Towards a tailored systemic therapy for liver cancer.

Authors:  Rodolfo Sacco; Antonio Facciorusso
Journal:  Ann Transl Med       Date:  2020-10

2.  Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.

Authors:  Yu Zhang; Xiaofeng Zhang; Jinling Zhang; Bin Sun; Lulu Zheng; Jun Li; Sixiu Liu; Guodong Sui; Zhengfeng Yin
Journal:  Cancer Biol Ther       Date:  2016-09-23       Impact factor: 4.742

3.  Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Yun-Long Lu; Jin-Guang Yao; Xiao-Ying Huang; Chao Wang; Xue-Min Wu; Qiang Xia; Xi-Dai Long
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

4.  Micro RNA-4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy.

Authors:  Tian-Qi Zhang; Qun-Qing Su; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Qiang Xia; Xi-Dai Long; Yun Ma
Journal:  Hepatol Commun       Date:  2018-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.